Moneycontrol PRO
HomeAuthorNeethi rojan

Neethi Rojan

News Trainee

Moneycontrol

No timeline for resuming supply from Mohali plant: Sun Pharma

BUSINESS

No timeline for resuming supply from Mohali plant: Sun Pharma

The company also said that the full effect of national list of essential medicines (NLEM) is visible in this quarter.

Eris Lifesciences gets thumbs up from analysts on pure-domestic play, foray into dermatology

BUSINESS

Eris Lifesciences gets thumbs up from analysts on pure-domestic play, foray into dermatology

A series of value accretive acquisitions in the dermatology space have improved prospects for the drugmaker

India achieves 93% coverage for DPT vaccines; 1.6 mn children still not covered fully: WHO-UNICEF report

TRENDS

India achieves 93% coverage for DPT vaccines; 1.6 mn children still not covered fully: WHO-UNICEF report

104 countries achieved at least 90 percent coverage of the DPT-3 vaccine

Aurobindo Pharma’s plant in Anakapalli classified as VAI by US FDA

BUSINESS

Aurobindo Pharma’s plant in Anakapalli classified as VAI by US FDA

The VAI status means that the US Food and Drug Administration will not take any regulatory action because the objectionable conditions if found are minor and may not qualify for any action.

Population-Health Equation: Experts urge greater investment in primary care

TRENDS

Population-Health Equation: Experts urge greater investment in primary care

As India surpasses China as the most populous country in the world, experts say that the allocation from the Government of India is considerably lower than the projected demand for the National Health Mission and that more decentralisation of primary healthcare is needed

Suicides due to drug and alcohol addiction in India tripled since 2011

INDIA

Suicides due to drug and alcohol addiction in India tripled since 2011

There is a very high risk of suicide among victims of substance abuse, says experts. And the number of NDPS (Narcotic Drugs and Psychotropic Substances) Act cases have gone up nearly 204 percent in the last decade.

Gennova's mRNA jab gets regulator nod, 1.2 million boosters approved by CDL Kasauli

INDIA

Gennova's mRNA jab gets regulator nod, 1.2 million boosters approved by CDL Kasauli

The Department of Biotechnology (DBT) on June 20 announced that the Omicron-specific mRNA-based booster vaccine developed using the indigenous platform technology by Gennova was supported under the Mission Covid Suraksha.

World Blood Donor Day: Indian blood banks struggle with dismal facilities

TRENDS

World Blood Donor Day: Indian blood banks struggle with dismal facilities

About 66 percent of blood banks in India were in the low- and medium-performance categories, according to a study in 2021, reporting administrative and technical gaps, including adherence to quality management systems and practices.

Does the diabetes pill metformin reduce long-Covid symptoms? Experts differ

TRENDS

Does the diabetes pill metformin reduce long-Covid symptoms? Experts differ

A study published in the Lancet Journal of Infectious Diseases found that early use of a two-week course metformin reduced the risk of long Covid.

Bharat Biotech recalls batch of typhoid vaccine after CDSCO red flag

INDIA

Bharat Biotech recalls batch of typhoid vaccine after CDSCO red flag

The TYPBAR vaccine was first in India to get a World Health Organisation Good Manufacturing Practice (WHO-GMP) prequalification certificate

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347